Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005088 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00005088: Completed Phase 2 study, sponsored by Radiation Therapy Oncology Group.
NCT00005088 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005088, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy and cisplatin in treating patients who have advanced head and neck cancer.
Interventions
- DRUG cisplatin
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-04 |
| Phase | Phase 2 |
What the finished NCT00005088 record still lists
NCT00005088 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which cisplatin is the first listed.
NCT00005088 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005088 about?
NCT00005088 is a clinical study titled "Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...
What is the current status of trial NCT00005088?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-04.
What interventions are being tested in trial NCT00005088?
The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00005088?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia